Mandate

Vinge advises Wilson Therapeutics in connection with the offer from Alexion

April 11, 2018

Alexion has announced a public cash offer to the shareholders of Wilson Therapeutics AB.


The offer values Wilson Therapeutics at approximately SEK 6,564 million. 
 
Vinge advises Wilson Therapeutics in connection with the offer. Vinge’s team is primarily composed of Erik Sjöman, Christian Lindhé, Astrid Karlsson and Philip Åberg. 

Related

Vinge advises on the sale of Compab to Tången

Vinge has advised the owners of Compab Energiteknik in connection with the sale of 80 per cent of the shares to Tången Industrikapital. Compab, which has a turnover of approximately SEK 100 million, sells, installs and services, amongst other things, steam and hot-water boilers as well as burners for the industrial sector.
October 26, 2026

Vinge advises Capio on the acquisition of Rehabhotellet Sthlm AB

Rehabhotellet i Sthlm AB provides advanced home healthcare and specialized inpatient palliative care within the Stockholm Region.
October 26, 2026

Vinge advises Ikano Bank on acquisition of loan portfolio from Entercard

Vinge has advised Ikano Bank AB (publ) on the acquisition of a portfolio of performing consumer loans from Entercard Group AB. As at 30 September 2026, the contractual amount of the loans totalled approximately SEK 7 billion.
October 26, 2026